XML 35 R24.htm IDEA: XBRL DOCUMENT v3.20.4
Note 2 - Revenue Recognition (Tables)
9 Months Ended
Dec. 31, 2020
Notes Tables  
Disaggregation of Revenue [Table Text Block]
  

Three Months Ended December 31, 2020

 
  

Sterilization and Disinfection Control

  

Instruments

  

Biopharmaceutical Development

  

Continuous Monitoring

  

Corporate and Other

  

Total

 

Discrete Revenues

                        
Consumables $11,250  $717  $3,406  $9  $-  $15,382 

Hardware and Software

  151   6,210   3,771   1,920   -   12,052 

Services

  433   2,042   506   799   -   3,780 

Contracted Revenues

                        

Services

  1,243   2   1,028   685   -   2,958 

Total Revenues

 $13,077  $8,971  $8,711  $3,413  $-  $34,172 
  

Three Months Ended December 31, 2019

 
  

Sterilization and Disinfection Control

  

Instruments

  

Biopharmaceutical Development

  

Continuous Monitoring

  

Corporate and Other

  

Total

 

Discrete Revenues

                        
Consumables $9,948  $781  $1,941  $13  $229  $12,912 

Hardware and Software

  95   6,881   2,571   2,562   -   12,109 

Services

  360   2,352   656   849   -   4,217 

Contracted Revenues

                        

Services

  1,216   -   469   732   -   2,417 

Total Revenues

 $11,619  $10,014  $5,637  $4,156  $229  $31,655 
  

Nine Months Ended December 31, 2020

 
  

Sterilization and Disinfection Control

  

Instruments

  

Biopharmaceutical Development

  

Continuous Monitoring

  

Corporate and Other

  

Total

 

Discrete Revenues

                        
Consumables $32,252  $2,240  $8,583  $54  $-  $43,129 

Hardware and Software

  388   16,045   10,518   6,082   -   33,033 

Services

  1,389   5,922   2,293   1,944   -   11,548 

Contracted Revenues

                        

Services

  3,667   2   2,397   2,197   -   8,263 

Total Revenues

 $37,696  $24,209  $23,791  $10,277  $-  $95,973 
  

Nine Months Ended December 31, 2019

 
  

Sterilization and Disinfection Control

  

Instruments

  

Biopharmaceutical Development

  

Continuous Monitoring

  

Corporate and Other

  

Total

 

Discrete Revenues

                        
Consumables $30,487  $2,364  $1,941  $34  $2,415  $37,241 

Hardware and Software

  429   19,282   2,571   6,374   -   28,656 

Services

  1,301   6,872   656   1,959   27   10,815 

Contracted Revenues

                        

Services

  3,606   -   469   2,692   -   6,767 

Total Revenues

 $35,823  $28,518  $5,637  $11,059  $2,442  $83,479 
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
  

Three Months Ended December 31,

  

Nine Months Ended December 31,

 
  

2020

  

2019

  

2020

  

2019

 

United States

 $18,480  $17,810  $52,246  $48,007 

Foreign

  15,692   13,845   43,727   35,472 

Total revenues

 $34,172  $31,655  $95,973  $83,479 
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]

Contract liabilities balance as of March 31, 2020

$7,217 

Prior year liabilities recognized in revenues during the nine months ended December 31, 2020

 (4,131)

Contract liabilities added during the nine months ended December 31, 2020, net of revenues recognized

 4,984 

Contract liabilities balance as of December 31, 2020

$8,070